125 related articles for article (PubMed ID: 26077493)
1. Design and synthesis of imidazole N-H substituted amide prodrugs as inhibitors of hepatitis C virus replication.
Zong X; Cai J; Chen J; Wang P; Zhou G; Chen B; Li W; Ji M
Bioorg Med Chem Lett; 2015 Aug; 25(16):3147-50. PubMed ID: 26077493
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
3. Aspartic acid based nucleoside phosphoramidate prodrugs as potent inhibitors of hepatitis C virus replication.
Maiti M; Maiti M; Rozenski J; De Jonghe S; Herdewijn P
Org Biomol Chem; 2015 May; 13(18):5158-74. PubMed ID: 25849139
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication.
Ding Y; Girardet JL; Hong Z; Lai VC; An H; Koh YH; Shaw SZ; Zhong W
Bioorg Med Chem Lett; 2005 Feb; 15(3):709-13. PubMed ID: 15664842
[TBL] [Abstract][Full Text] [Related]
5. INX-08189, a phosphoramidate prodrug of 6-O-methyl-2'-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties.
Vernachio JH; Bleiman B; Bryant KD; Chamberlain S; Hunley D; Hutchins J; Ames B; Gorovits E; Ganguly B; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters CR; Wang J; Williams K; Patti JM; Henson G; Madela K; Aljarah M; Gilles A; McGuigan C
Antimicrob Agents Chemother; 2011 May; 55(5):1843-51. PubMed ID: 21357300
[TBL] [Abstract][Full Text] [Related]
6. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
Gunic E; Girardet JL; Ramasamy K; Stoisavljevic-Petkov V; Chow S; Yeh LT; Hamatake RK; Raney A; Hong Z
Bioorg Med Chem Lett; 2007 May; 17(9):2452-5. PubMed ID: 17331721
[TBL] [Abstract][Full Text] [Related]
7. Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.
Stachulski AV; Pidathala C; Row EC; Sharma R; Berry NG; Lawrenson AS; Moores SL; Iqbal M; Bentley J; Allman SA; Edwards G; Helm A; Hellier J; Korba BE; Semple JE; Rossignol JF
J Med Chem; 2011 Dec; 54(24):8670-80. PubMed ID: 22059983
[TBL] [Abstract][Full Text] [Related]
8. A 96-well based analysis of replicon elimination with the HCV NS5A replication complex inhibitor daclatasvir.
O'Boyle DR; Nower PT; Sun JH; Fridell R; Wang C; Valera L; Gao M
J Virol Methods; 2013 Oct; 193(1):68-76. PubMed ID: 23684844
[TBL] [Abstract][Full Text] [Related]
9. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
[TBL] [Abstract][Full Text] [Related]
10. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
[TBL] [Abstract][Full Text] [Related]
11. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Structure-Activity Relationships of Imidazole-Coumarin Conjugates against Hepatitis C Virus.
Tsay SC; Lin SY; Huang WC; Hsu MH; Hwang KC; Lin CC; Horng JC; Chen IC; Hwu JR; Shieh FK; Leyssen P; Neyts J
Molecules; 2016 Feb; 21(2):. PubMed ID: 26901180
[TBL] [Abstract][Full Text] [Related]
13. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
[TBL] [Abstract][Full Text] [Related]
14. Novel amides and esters prodrugs of olmesartan: Synthesis, bioconversion, and pharmacokinetic evaluation.
Park JH; Chang JS; El-Gamal MI; Choi WK; Lee WS; Chung HJ; Kim HI; Cho YJ; Lee BS; Jeon HR; Lee YS; Choi YW; Lee J; Oh CH
Bioorg Med Chem Lett; 2010 Oct; 20(19):5895-9. PubMed ID: 20728357
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Brancale A; Zonta N; Chamberlain S; Vernachio J; Hutchins J; Hall A; Ames B; Gorovits E; Ganguly B; Kolykhalov A; Wang J; Muhammad J; Patti JM; Henson G
Bioorg Med Chem Lett; 2010 Aug; 20(16):4850-4. PubMed ID: 20637609
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors.
Kang IJ; Wang LW; Yeh TK; Lee CC; Lee YC; Hsu SJ; Wu YS; Wang JC; Chao YS; Yueh A; Chern JH
Bioorg Med Chem; 2010 Sep; 18(17):6414-21. PubMed ID: 20675142
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehyde.
Bowman RK; Brown AD; Cobb JH; Eaddy JF; Hatcher MA; Leivers MR; Miller JF; Mitchell MB; Patterson DE; Toczko MA; Xie S
J Org Chem; 2013 Dec; 78(23):11680-90. PubMed ID: 24171666
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C replication inhibitors that target the viral NS4B protein.
Miller JF; Chong PY; Shotwell JB; Catalano JG; Tai VW; Fang J; Banka AL; Roberts CD; Youngman M; Zhang H; Xiong Z; Mathis A; Pouliot JJ; Hamatake RK; Price DJ; Seal JW; Stroup LL; Creech KL; Carballo LH; Todd D; Spaltenstein A; Furst S; Hong Z; Peat AJ
J Med Chem; 2014 Mar; 57(5):2107-20. PubMed ID: 23544424
[TBL] [Abstract][Full Text] [Related]
19. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
[TBL] [Abstract][Full Text] [Related]
20. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection.
Gardelli C; Attenni B; Donghi M; Meppen M; Pacini B; Harper S; Di Marco A; Fiore F; Giuliano C; Pucci V; Laufer R; Gennari N; Marcucci I; Leone JF; Olsen DB; MacCoss M; Rowley M; Narjes F
J Med Chem; 2009 Sep; 52(17):5394-407. PubMed ID: 19725579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
